Global Medical REIT Management

Management criteria checks 2/4

Global Medical REIT's CEO is Jeff Busch, appointed in Aug 2015, has a tenure of 9.25 years. total yearly compensation is $2.18M, comprised of 32.1% salary and 67.9% bonuses, including company stock and options. directly owns 0.065% of the company’s shares, worth €364.15K. The average tenure of the management team and the board of directors is 8.7 years and 8.7 years respectively.

Key information

Jeff Busch

Chief executive officer

US$2.2m

Total compensation

CEO salary percentage32.1%
CEO tenure9.3yrs
CEO ownership0.07%
Management average tenure8.7yrs
Board average tenure8.7yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Jeff Busch's remuneration changed compared to Global Medical REIT's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$1m

Jun 30 2024n/an/a

-US$56k

Mar 31 2024n/an/a

US$15m

Dec 31 2023US$2mUS$700k

US$15m

Sep 30 2023n/an/a

US$16m

Jun 30 2023n/an/a

US$21m

Mar 31 2023n/an/a

US$11m

Dec 31 2022US$2mUS$650k

US$13m

Sep 30 2022n/an/a

US$17m

Jun 30 2022n/an/a

US$12m

Mar 31 2022n/an/a

US$13m

Dec 31 2021US$2mUS$600k

US$12m

Sep 30 2021n/an/a

US$9m

Jun 30 2021n/an/a

-US$5m

Mar 31 2021n/an/a

-US$7m

Dec 31 2020US$3mUS$298k

-US$8m

Sep 30 2020n/an/a

-US$8m

Jun 30 2020n/an/a

US$3m

Mar 31 2020n/an/a

US$4m

Dec 31 2019US$455kn/a

US$3m

Sep 30 2019n/an/a

US$9m

Jun 30 2019n/an/a

US$9m

Mar 31 2019n/an/a

US$8m

Dec 31 2018US$396kn/a

US$8m

Sep 30 2018n/an/a

US$440k

Jun 30 2018n/an/a

US$535k

Mar 31 2018n/an/a

-US$23k

Dec 31 2017US$673kn/a

-US$2m

Compensation vs Market: Jeff's total compensation ($USD2.18M) is above average for companies of similar size in the German market ($USD1.05M).

Compensation vs Earnings: Jeff's compensation has increased whilst the company is unprofitable.


CEO

Jeff Busch (64 yo)

9.3yrs

Tenure

US$2,181,100

Compensation

Mr. Jeffrey M. Busch, also known as Jeff, is Director of IMAC Holdings, Inc. from September 19, 2024. Mr. Busch is Chairman of the Board at Theralink Technologies, Inc. (formerly known as OncBioMune Pharma...


Leadership Team

NamePositionTenureCompensationOwnership
Jeffrey Busch
Chairman9.3yrsUS$2.18m0.065%
€ 364.2k
Robert Kiernan
CFO & Treasurer7.3yrsUS$1.41m0%
€ 0
Danica Holley
Chief Operating Officer8.7yrsUS$935.78k0.00075%
€ 4.2k
Alfonzo Leon
Chief Investment Officer9.3yrsUS$1.34m0%
€ 0
Jamie Barber
General Counsel & Corporate Secretary7.5yrsUS$872.70k0%
€ 0
Mary Jensen
Investor Relations Professionalno datano datano data

8.7yrs

Average Tenure

51yo

Average Age

Experienced Management: 3UN's management team is seasoned and experienced (8.7 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Jeffrey Busch
Chairman10.2yrsUS$2.18m0.065%
€ 364.2k
Ronald Marston
Independent Director9.3yrsUS$155.71k0.012%
€ 65.6k
Henry Cole
Lead Independent Director9.3yrsUS$183.21k0.012%
€ 64.7k
Paula Crowley
Independent Director6.4yrsUS$177.77k0%
€ 0
Lori Wittman
Independent Director6.5yrsUS$203.10k0%
€ 0
Matthew Cypher
Independent Director8.7yrsUS$153.48k0%
€ 0
Huiqi Zhang
Director8.7yrsno data0%
€ 0

8.7yrs

Average Tenure

65yo

Average Age

Experienced Board: 3UN's board of directors are considered experienced (8.7 years average tenure).